Can BioMarin Pharmaceutical Inc. (BMRN) stock recover despite sales dropping?

In yesterday’s Wall Street session, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares traded at $85.00, down -1.94% from the previous session. 26 analysts cover BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $200.00 and a […]